ArticleJournal of Korean medical science2025
Epidemiology of Femoroacetabular Impingement in Korea.
Article in Journal of Korean medical science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Diagnostic performance of multimodal imaging integrating X-ray, CT, and MRI in femoroacetabular impingement syndrome.American journal of translational research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundFemoroacetabular impingement (FAI) is increasingly recognized as a significant cause of hip and groin pain. Despite the rising awareness, epidemiological data on FAI remain limited in East Asia. This study aimed to investigate the prevalence, treatment patterns, and associated medical costs of FAI in South Korea.
methodsTo identify patients with FAI, a nationwide claims database from the Korean Health Insurance Review and Assessment Service (HIRA) was used from January 2013 to December 2022. The patients were identified using the International Classification of Diseases, 10th Revision codes for FAI. Patients aged 15 years and older were grouped into 5-year age intervals and categorized according to gender. The overall crude and age-adjusted prevalence were assessed from 2013 to 2022 using the Korean Statistical Information Service (KOSIS). Patients were further categorized into those undergoing surgical treatment and conservative treatments. To assess the economic burden of the disease, we estimated the total medical and out-of-pocket costs reimbursed for patients diagnosed with these codes.
resultsDuring the study period, 39,620 patients were considered to have the diagnosis of FAI. Among them, 2,884 patients were hospitalized, including 1,562 men and 1,322 women. The number of hospitalized patients slightly decreased from 303 in 2013 to 281 in 2022. However, the total number of patients increased significantly from 2,721 in 2013 to 5,196 in 2022. When stratified by age in 5-year intervals, a bimodal distribution was observed for men and an unimodal distribution for women, with a peak in the 50s. The age-adjusted prevalence showed an annual increase of 7.14% (95% confidence interval [CI], 4.56-10.22;
conclusionThis study highlights the significant increase in FAI prevalence and related healthcare costs in South Korea. However, only a minority of FAI patients underwent surgical treatment during the study period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.